| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.50T | 3.55T | 3.76T | 3.71T | 3.59T |
| Gross Profit | 1.25T | 1.17T | 1.16T | 1.14T | 1.12T |
| EBITDA | 360.15B | 399.83B | 440.94B | 457.57B | 446.38B |
| Net Income | 449.41B | 219.81B | 254.48B | 215.18B | 182.69B |
Balance Sheet | |||||
| Total Assets | 3.40T | 3.50T | 3.51T | 3.27T | 3.33T |
| Cash, Cash Equivalents and Short-Term Investments | 450.37B | 236.08B | 342.14B | 355.90B | 484.02B |
| Total Debt | 133.09B | 247.09B | 245.68B | 211.18B | 285.32B |
| Total Liabilities | 1.36T | 1.60T | 1.60T | 1.53T | 1.62T |
| Stockholders Equity | 2.02T | 1.74T | 1.75T | 1.59T | 1.59T |
Cash Flow | |||||
| Free Cash Flow | 229.15B | 142.98B | 113.38B | 52.23B | 105.10B |
| Operating Cash Flow | 338.13B | 303.88B | 309.22B | 220.33B | 248.35B |
| Investing Cash Flow | 140.80B | -114.16B | -159.91B | -42.81B | -59.27B |
| Financing Cash Flow | -376.06B | -215.47B | -178.82B | -313.58B | -193.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥5.48T | 9.99 | 12.48% | 0.55% | 4.65% | 54.39% | |
67 Neutral | ¥5.33T | 13.04 | 15.02% | 0.68% | -1.33% | 108.40% | |
64 Neutral | ¥763.29B | 20.55 | ― | 1.39% | 5.45% | 7.26% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥652.55B | 17.25 | 10.07% | 1.76% | 12.72% | 13.98% | |
59 Neutral | ¥2.38T | -9.13 | 22.48% | 1.14% | 6.52% | -83.73% |